SCHEMBL1991264

SCHEMBL1991264

[2H]C([2H])([2H])C([2H])(N(C(=O)C[C@H](c1ccccc1)c1cc(COCc2ccccc2)ccc1OCc1ccccc1)C([2H])(C([2H])([2H])[2H])C([2H])([2H])[2H])C([2H])([2H])[2H]

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACP1 P24666 1/20 0.38
PTPN12 Q05209 1/20 0.38
PTPN13 Q12923 1/20 0.38
SSU72 Q9NP77 1/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38
THRB P10828 1/20 0.38
MRGPRX4 Q96LA9 1/20 0.38
APP P05067 1/20 0.37
FFAR4 Q5NUL3 1/20 0.37
LMNA P02545 2/20 0.37
ALOX5 P09917 1/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
FOLH1 Q04609 1/20 0.36
F2 P00734 1/20 0.36
F10 P00742 1/20 0.36
PRSS1 P07477 1/20 0.36
PRSS2 P07478 1/20 0.36
F7 P08709 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1990015 0.93 ACP1 (0.37) ACP1PTPN12PTPN13SSU72POLB
SCHEMBL1991102 0.89 KMT2A (0.43) ACP1PTPN12PTPN13SSU72MRGPRX4
SCHEMBL1994388 0.88 KMT2A (0.39) ACP1PTPN12PTPN13SSU72POLB
SCHEMBL1990399 0.84 KMT2A (0.47) ACP1PTPN12PTPN13SSU72MRGPRX4
SCHEMBL1990402 0.84 KMT2A (0.47) ACP1PTPN12PTPN13SSU72MRGPRX4
SCHEMBL1995601 0.82 CHRM2 (0.39) ACP1PTPN12PTPN13SSU72POLB
SCHEMBL1994011 0.81 CHRM2 (0.43) ACP1PTPN12PTPN13SSU72POLB
SCHEMBL1992692 0.80 FOLH1 (0.42) ACP1PTPN12PTPN13SSU72MAPT
SCHEMBL1992690 0.80 FOLH1 (0.42) ACP1PTPN12PTPN13SSU72MAPT
SCHEMBL1991544 0.78 KMT2A (0.40) ACP1PTPN12PTPN13SSU72MRGPRX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152227-A1 DEUTERIUM LABELLED DERIVATIVES OF 3-(2-HYDROXY-5-METHYPHENYL)-N,N-DIISOPROPYL-3-PHENYLPROPYLAMINE AND METHODS OF USE THEREOF CONCERT PHARMACEUTICALS INC. (US) 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152227-A1 DEUTERIUM LABELLED DERIVATIVES OF 3-(2-HYDROXY-5-METHYPHENYL)-N,N-DIISOPROPYL-3-PHENYLPROPYLAMINE AND METHODS OF USE THEREOF ADRB3, CHRM3, QDPR ACP1 4342/4885PTPN12 3011/4885PTPN13 2732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.